2016 Q2 Form 10-Q Financial Statement

#000114420416127865 Filed on October 12, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $2.936M $2.936M
YoY Change 0.0% 16.79%
Cost Of Revenue $2.120M $2.050M
YoY Change 3.41% 7.89%
Gross Profit $1.063M $882.4K
YoY Change 20.46% 44.31%
Gross Profit Margin 36.2% 30.05%
Selling, General & Admin $1.114M $1.164M
YoY Change -4.3% -2.0%
% of Gross Profit 104.77% 131.88%
Research & Development $137.6K $200.3K
YoY Change -31.29% 23.67%
% of Gross Profit 12.95% 22.7%
Depreciation & Amortization $7.874K $9.385K
YoY Change -16.1% -20.04%
% of Gross Profit 0.74% 1.06%
Operating Expenses $1.251M $1.364M
YoY Change -8.26% 1.08%
Operating Profit -$188.4K -$481.7K
YoY Change -60.89% -34.73%
Interest Expense $4.236K -$300.0K
YoY Change -101.41%
% of Operating Profit
Other Income/Expense, Net -$4.236K -$8.282K
YoY Change -48.85%
Pretax Income -$390.0K -$777.1K
YoY Change -49.81% 4.61%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$777.1K -$777.1K
YoY Change 0.0% 4.61%
Net Earnings / Revenue -26.46% -26.46%
Basic Earnings Per Share -$0.34
Diluted Earnings Per Share -$168.8K -$0.34
COMMON SHARES
Basic Shares Outstanding 2.313M shares
Diluted Shares Outstanding 2.313M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $180.0K $250.0K
YoY Change -28.0% -91.55%
Cash & Equivalents $175.8K $253.4K
Short-Term Investments
Other Short-Term Assets $600.0K $480.0K
YoY Change 25.0% 37.14%
Inventory $4.510M $4.680M
Prepaid Expenses
Receivables $340.0K $930.0K
Other Receivables $1.730M $1.330M
Total Short-Term Assets $7.350M $7.670M
YoY Change -4.17% -9.12%
LONG-TERM ASSETS
Property, Plant & Equipment $60.00K $100.0K
YoY Change -40.0% -26.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $11.40M $12.56M
YoY Change -9.25% -11.07%
Other Assets $10.00K $30.00K
YoY Change -66.67% -21.33%
Total Long-Term Assets $11.53M $12.76M
YoY Change -9.62% -11.25%
TOTAL ASSETS
Total Short-Term Assets $7.350M $7.670M
Total Long-Term Assets $11.53M $12.76M
Total Assets $18.88M $20.43M
YoY Change -7.57% -10.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.950M $1.940M
YoY Change 52.06% 172.39%
Accrued Expenses $110.0K $170.0K
YoY Change -35.29% -22.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $430.0K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.070M $2.540M
YoY Change 20.87% 154.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.070M $2.540M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.070M $2.540M
YoY Change 20.87% 146.6%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $12.91M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.82M $17.89M
YoY Change
Total Liabilities & Shareholders Equity $18.88M $20.43M
YoY Change -7.59% -10.43%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$777.1K -$777.1K
YoY Change 0.0% 4.61%
Depreciation, Depletion And Amortization $7.874K $9.385K
YoY Change -16.1% -20.04%
Cash From Operating Activities $290.0K -$854.7K
YoY Change -133.93% -194.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$160.0K
YoY Change
Cash From Investing Activities -$160.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -310.0K $426.7K
YoY Change -172.65%
NET CHANGE
Cash From Operating Activities 290.0K -$854.7K
Cash From Investing Activities -160.0K $0.00
Cash From Financing Activities -310.0K $426.7K
Net Change In Cash -180.0K -$428.0K
YoY Change -57.94% -147.21%
FREE CASH FLOW
Cash From Operating Activities $290.0K -$854.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
11740633 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-784927 USD
CY2016Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2016Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
313891 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3178607 USD
CY2015Q2 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
1911257 USD
CY2016Q2 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
2043027 USD
CY2015Q2 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
142806 USD
CY2016Q2 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
72586 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
882427 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
1062994 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-777077 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-389679 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4236 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8282 USD
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2312887 shares
CY2015Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2016Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-166303 USD
CY2015Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-93515 USD
CY2016Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-16580 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-93515 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-182883 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-870592 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-572562 USD
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9385 USD
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7874 USD
CY2015Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q2 uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
470055 USD
CY2016Q2 uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
137066 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
964984 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1260118 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-854703 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
288221 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
631906 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-161305 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
426732 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-313891 USD
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
203935 USD
CY2015Q2 us-gaap Interest Paid
InterestPaid
9785 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-186975 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49427 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
253362 USD
CY2016Q2 us-gaap Interest Paid
InterestPaid
4236 USD
CY2016Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
869073 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
650112 USD
CY2016Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
-313891 USD
CY2015Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
426732 USD
CY2016Q2 dei Document Type
DocumentType
10-Q
CY2016Q2 dei Amendment Flag
AmendmentFlag
false
CY2016Q2 dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
CY2016Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2016Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q2 dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
CY2016Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000102109
CY2016Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2016Q2 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q2 dei Trading Symbol
TradingSymbol
UUU
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887 shares
CY2016Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
401845 USD
CY2016Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
139985 USD
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2016Q1 uuu Working Capital
WorkingCapital
4463601 USD
CY2016Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
5589468 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
6024586 USD
CY2016Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
5115432 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
6024586 USD
CY2016Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
28582355 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
31066085 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200303 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
366307 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
4612505 USD
CY2016Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2016Q2 uuu Increase Decrease In Funds Held By Factor
IncreaseDecreaseInFundsHeldByFactor
-161305 USD
CY2015Q2 uuu Increase Decrease In Funds Held By Factor
IncreaseDecreaseInFundsHeldByFactor
631906 USD
CY2016Q2 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Basis of Presentation</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The condensed consolidated financial statements include the accounts of Universal Security Instruments, Inc. (USI or the Company) and its majority owned subsidiary. Except for the condensed consolidated balance sheet as of March 31, 2016, which was derived from audited financial statements, the accompanying condensed consolidated financial statements are unaudited. Significant inter-company accounts and transactions have been eliminated in consolidation. In the opinion of the Company&#8217;s management, the interim condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (US-GAAP) have been condensed or omitted. The interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s March 31, 2016 audited financial statements filed with the Securities and Exchange Commission (SEC) on Form 10-K filed on September 28, 2016. The interim operating results are not necessarily indicative of the operating results for the full fiscal year.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2600000 USD
CY2015Q1 us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
The Agreement for the assignment of accounts receivable expires on January 6, 2018 and provides for continuation of the program on successive two year periods until terminated by one of the parties to the Agreement. In accordance with the provisions of the Agreement, the Company may take advances equal to eighty percent (80%) of the uncollected non-recourse factored trade accounts receivable balance less applicable factoring commissions and may borrow up to fifty percent (50%) of eligible inventories subject to a borrowing limitation on inventory of $1,000,000.
CY2015Q1 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
bears interest at the prime commercial rate of interest, as published, plus two percent (Effective rate 5.50% at June 30, 2016).
CY2016Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
2485000 USD
CY2015Q1 uuu Accounts Receivables Factoring Agreement Expiration Date
AccountsReceivablesFactoringAgreementExpirationDate
2018-01-06
CY2015Q1 uuu Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
P2Y
CY2016Q2 uuu Increase Decrease In Working Capital
IncreaseDecreaseInWorkingCapital
184719 USD
CY2016Q2 uuu Working Capital
WorkingCapital
4278882 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1113720 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1163786 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
137631 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-2137792 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-3704985 USD

Files In Submission

Name View Source Status
0001144204-16-127865-index-headers.html Edgar Link pending
0001144204-16-127865-index.html Edgar Link pending
0001144204-16-127865.txt Edgar Link pending
0001144204-16-127865-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlogo.jpg Edgar Link pending
uuu-20160630.xml Edgar Link completed
uuu-20160630.xsd Edgar Link pending
uuu-20160630_cal.xml Edgar Link unprocessable
uuu-20160630_def.xml Edgar Link unprocessable
uuu-20160630_lab.xml Edgar Link unprocessable
uuu-20160630_pre.xml Edgar Link unprocessable
v445758_10q.htm Edgar Link pending
v445758_ex31-1.htm Edgar Link pending
v445758_ex31-2.htm Edgar Link pending
v445758_ex32-1.htm Edgar Link pending
v445758_ex99-1.htm Edgar Link pending